Rundu Pharmaceutical (002923.SZ) released its first three quarters performance, with a net profit attributable to shareholders of RMB 65.6 million, turning losses into profits year-on-year.

Zhitong Finance APP News, Rundu Co., Ltd. (002923.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 1.07 billion yuan, a year-on-year increase of 20.98%; net profit attributable to shareholders of the listed company was 65.60 million yuan, turning from loss to profit year-on-year; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 55.2065 million yuan; basic earnings per share were 0.2 yuan.